Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
Go back to Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune| INOVIO PHARMACEUTICALS, Inc. (NASDAQ: INO) | Delayed: 1.13 +0.02 (1.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.11 | 52 Week High | $11.69 | |||
| Open | $1.09 | 52 Week Low | $4.50 | |||
| Day High | $1.16 | P/E | N/A | |||
| Day Low | $1.09 | EPS | $-0.28 | |||
| Volume | 1,176,689 | |||||
